CTOs on the Move

IPS Research Company

www.ipsresearch.com

 
IPS Research Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oklahoma City, OK. To find more information about IPS Research Company, please visit www.ipsresearch.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.ipsresearch.com
  • 1111 N Lee Ave Ste 400
    Oklahoma City, OK USA 73103-2620
  • Phone: 405.235.8188

Executives

Name Title Contact Details

Similar Companies

Virginia Premier Health Plan Inc

Virginia Premier Health Plan, Inc. is a Health Maintenance Organization (HMO, IPA model), which began operations as a full service Medicaid HMO in August 1995. VPHP is contracted with the Virginia Department of Medical Assistance Services to provide

Healthworks Fitness

Healthworks Fitness is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parma Care Ctr

Parma Care Ctr is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sophono

Sophono is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ambrx

Ambrx®, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics using an expanded genetic code. Unlike conventional conjugation techniques that create a mixture of suboptimal molecules, Ambrx technology combines site specific conjugation with proprietary linkers, payloads and pharmacokinetic extenders to create a single molecular species that is optimized for safety, efficacy and biophysical properties. We call this process Protein Medicinal Chemistry™. Protein Medicinal Chemistry™ can optimize any protein or antibody to create potentially best-in-class therapeutics such as long-acting proteins, bi-specifics and antibody drug conjugates. The Ambrx advantage allows us to safely and effectively target cytotoxic agents or recruit effector function to tumor cells (oncology) or modulate biological pathways implicated in disease areas such as autoimmune, metabolic and cardiovascular. At Ambrx, we are dedicated to assembling and developing an exceptional team and a novel technology to create the next generation of protein-based medicines.